Locoregional post-mastectomy radiotherapy for breast cancer: Literature review;La radiotherapie locoregionale postmastectomie pour cancer du sein: Analyse de la litterature

Cancer/Radiotherapie

Volumn 4, Issue 1, 2000, Pages 3-26

  Noel G ^a   Mazeron, J J ^b  

^a Ctr de Protontherapie d'Orsay   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Locoregional failure; Locoregional radiotherapy; Mastectomy; Metastatic relapse

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; LEVAMISOLE; MELPHALAN; METHOTREXATE; PHENYLALANINE; PREDNISONE; TAMOXIFEN; TEGAFUR; THIOTEPA; VINCRISTINE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MASTECTOMY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; ADJUVANT THERAPY; ADULT; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034052552     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(00)88648-5     Document Type: Review

References (108)

1. Aberizk WJ, Silver B, Henderson IC, Cady B, Harris JR. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 1986; 58: 1214-8.
2. Ahmann DL, O'Fallon JR, Scanlon PW, Payne WS, Bisel HF, Edmonson JH, et al. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol 1982; 5: 371-81.
3. Ahmann DL, Payne WS, Scanlon PW, O'Fallon JR, Bisel HF, Hahn RG, et al. Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide and prednisone with or without radiation after mastectomy for breast cancer. Lancet 1978; 1: 893-6.
4. Aitken RJ, Gaze MN, Rodger A, Chetty U, Forrest APM. Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg 1989; 76: 568-71.
5. Arriagada R, Le MG, Mouriesse H, Fontaine F, Dewar J, Rochard F, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 1988; 11: 213-22.
6. Arriagada R, Rutqvist LE, Mattson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869-78.
7. Auquier A, Rutqvist LE, Host H, Rotstein S, Arriagada R. Postmastectomy megavoltage radiotherapy: The Oslo and Stockholm trials. Eur J Cancer 1992; 28: 433-7.
8. Bates TD. Correspondance. Br J Radiol 1989; 62: 634.
9. Bates TD. The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. Br J Radiol 1988; 61: 625-30.
10. Bedwinek JM, Lee J, Fineberg B, Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 1981; 47: 2232-5.
11. Bentzen SM, Thames HD. Correspondance. Br J Radiol 1989; 62: 633-4.
12. Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989; 56: 711-5.
13. Bichert Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. Monogr Natl Cancer Inst 1992; 11: 19-25.
14. Blomqvist C, Tiusanen K, Elomaa I, Rissanen P, Hietanen T, Heinonen E, et al. The comination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomized trial. Br J Cancer 1992; 66: 1171-6.
15. Bolla M, Vrousos C, Husson B, Kolodie H, Vincent F, Bouchet Y, et al. L'irradiation postopératoire dans les cancers du sein. Analyse du contrôle locorégional, de la rémission métastatique et de la survie, à propos de 178 cas. Sem Hôp Paris 1980; 56: 1245-8.
16. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985; 5: 95-115.
17. Brady LW, Fletcher GH, Levitt SH. Cancer of the breast. The role of radiation therapy after mastectomy. Cancer 1977; 39: 2868-74.
18. Brinkley D, Haybittle JL, Houghton J. on behalf of the Cancer Research Campaign Working Party. The cancer research campaign (King's/Cambridge) trial for early breast cancer: An analysis of the radiotherapy data. Br J Radiol 1984; 57: 309-16.
19. Buzdar AU, Blumenschein GR, Smith TL, Powell KC, Hortobagyi GN, Yap HY, et al. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial. Cancer 1984; 53: 384-9.
20. Cancer Research Campaign Working Party. Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at tenth year. Lancet 1978; i: 55-60.
21. Chen KKY, Montague ED, Oswald MJ. Results of irradiation in the treatment of locoregional breast cancer recurrence. Cancer 1985; 56: 1269-73.
22. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, et al. Overview of randomized trials of post operative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15-29.
23. Cuzick J, Stewart H, Peto R, Fisher B, Kaae S, Johansen H, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 7-14.
24. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-53.
25. th ASTRO meeting. Radiat Oncol Biol Phys 1985; 11 Suppl 1: 150.
26. Davies JD, Rees GJG, Mera SL. Angiosarcoma in irradiated postmastectomy chest wall. Histopathology 1983: 7: 947-56.
27. Deigert F, Gunn W, Lindemann F, Stack T, Cherewick T. A blended beam technique to decrease toxic effects of post mastectomy irradiation by combining and sequentially mixing electrons and photons. Med Dosim 1995; 20: 183-90.
28. Dewar JA, Sarrazin D, Benhamou E, Petit JY, Benhamou S, Arriagada R. Management of the axilla in conservative treated breast cancer: 592 patients treated at Institut Gustave Roussy. Int J Radiat Oncol Biol Phys 1989; 13: 475-81.
29. Diab SG, Hilsenbeck SG, de Moor C, Clarck GM, Osborne CK, Ravdin PM. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol 1998; 16: 1655-60.
30. Dombernowsky P, Brincker H, Hansen M, Mouridsen HT, Overgaard M, Panduro J, et al. Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77b and 82b. Acta Oncol 1988; 27: 691-7.
31. Donegan WL, Stine SB, Samter GS. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993; 72: 778-82.
32. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333: 1444-55.
33. Fisher B, Fischer ER, Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 1986; 4: 929-41.
34. Fisher B, Montague E, Redmond C, Deutsch M, Brown GR, Zauber A, et al. Findings from NSABP protocol n° B-04- comparison of radical mastectomy with alternative treatments for primary breast cancer. I- radiation compliance and its relation to treatment outcome. Cancer 1980; 46: 1-13.
35. Fisher B, Redmond C, Fischer ER, Bauer M, Wolmark N, Wickerman L, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.
36. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerman L, et al. Eight-year results of randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822-8.
37. Fisher B, Slack NH, Cavanaugh PJ, Gardner B, Ravdin RG. Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial. Ann Surg 1970; 172: 711-30.
38. Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER and participating NSABP investigators. Findings from NSABP protocol n° B-04. Comparison of radical mastectomy with alternating treatment. II- The clinical and biologic significance of medial-central breast cancers. Cancer 1981; 48: 1863-72.
39. Fletcher GH, Montague ED. Does adequate irradiation of the internal mammary chain and supraclavicular nodes improve survival rates? Int J Radiat Oncol Biol Phys 1978; 4: 481-92.
40. Fletcher GH, McNeese MD, Oswald MJ. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy: An update. Int J Radiat Oncol Biol Phys 1989; 17: 11-4.
41. Forrest APM, Stewart HJ, Roberts MM, Steele RJC. Simple mastectomy and axillary nose sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 1992; 196: 371-8.
42. Fowble B. Postmastectomy radiation. A modest benefit prevails for high risk patients. J Clin Oncol 1997; 79: 1061-6.
43. Fowble B. Results of prospective randomized trials evaluating postmastectomy radiation for axillary node-positive patients receiving adjuvant systemic therapy. American Society of Clinical Oncology, 1999. Educational Book. p. 623-8.
44. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988; 6: 1107-17.
45. Freedman GM, Fowble BL, Hanlon AL, Myint MA, Hoffman JP, Sigurdson ER, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 1998; 41: 599-605.
46. Fuller SA, Haybittle JL, Smith REA, Dobbs HJ. Cardiac doses in post-operative breast irradiation. Radiother Oncol 1992; 25: 19-24.
47. Gelman R, Harris JR. Editorial comment on "the link between local recurrence and distant metastasis in human breast cancer" by Serge Koscielny and Maurice Tubiana. Int J Radiat Oncol Biol Phys 1999; 43: 7-9.
48. Goldhirsch A, Gelber R. Adjuvant treatment for early breast cancer: The Ludwig breast cancer studies, in NCI monograph. Proceedings of the NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Bethesda, MD, National Cancer Institut; 1986. p. 55-70.
49. Griem KL, Henderson IC, Gelman R, Ascoli D, Silver B, Recht A, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 1987; 5: 1546-55.
50. Green JP, Vaeth JMV, Lowy RO. Time-dose study in post operative breast irradiation four time versus five times weekly fractionation. Radiol Clin Biol 1969; 38: 197-204.
51. Gröhn P, Heinonen E, Klefström P, Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 1984; 54: 670-4.
52. Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998; 48: 185-90.
53. Haybittle JL, Brinkley D, Houghton J, A'Hern RP, Baum M. Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. Br Med J 1989; 298: 1611-4.
54. Holland JF, Glidewell O, Cooper RG. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast. Surg Gynecol Obstet 1980; 150: 817-21.
55. Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer-long term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986; 12: 727-32.
56. Houghton B, Baum M, Haybittle JL on behalf of the closed trials working party of the CRC breast cancer trials group. Role of radiotherapy following total mastectomy inpatients with early breast cancer. World J Surg 1994; 18: 117-22.
57. Hughson AVM, Cooper AF, McArdle CS, Smith DC. Psychosocial effects of radiotherapy after mastectomy. Br Med J 1987; 294: 1515-8.
58. Jackson SM, Gibb R. Electron beam therapy of the post mastectomy chest wall. Br J Radiol 1972; 45: 745-7.
59. Jacobson JA, Danworth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332: 907-11.
60. Jager JJ, Volovics L, Shouten LJ, de Jong JMA, Hupperets PSGJ, von Meyenfeldt MF, et al. Loco-regional recurrences after mastectomy in breast cancer prognostic factors and implication for postoperative irradiation. Radiother Oncol 1999; 50: 267-75.
61. Janjan NA, McNeese MD, Buzdar AU, Montague ED, Oswald MJ. Management of loco-regional recurrent breast cancer. Cancer 1986; 58: 1552-6.
62. Jefferies S, Yarnold J. Post-mastectomy radiotherapy: Is it cure after all? Eur J Cancer 1994; 30: 1600-1.
63. Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 1989; 40: 204-8.
64. Klefström P, Gröhn P, Heinonen E, Holsti L, Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. 5-years results and influence of levamisole. Cancer 1987; 60: 936-42.
65. Koscielny S, Tubiana M. The link between local recurrence and distant metastasis in human breast cancer. Int J Radiat Oncol Biol Phys 1999; 43: 11-24.
66. Kurtz JM. Radiotherapy in the curative treatment of breast cancer: Current status and future trends. Radiother Oncol 1994; 32: 21-8.
67. Kuske RR. The role of postmastectomy radiation in the treatment of early-stage breast cancer. Taps or a call to arms. American Society of Clinical Oncology, 1999. Educational Book. p. 629-33.
68. Lacour J, Bucalossi P, Cagers E, Jacobelli G, Koszarowski T, Le M, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissections. Cancer 1976; 37: 206-14.
69. Levitt SH. Is there a role for radiotherapy for post operative adjuvant radiation in breast cancer? Beautiful hypothesis versus ugly facts: 1987 Gilbert H. Fletcher lecture. Int J Radiat Oncol Biol Phys 1988; 14: 787-96.
70. Levitt SH, Khan FM, Boen JR, Potish RA, Bowers BJ. Multimodal therapy in the treatment of breast cancer. Am J Clin Oncol 1983; 6: 387-91.
71. Levitt SH, Polish RA, Boen JR, Lindgren B. The effect of definitive irradiation on local control and desease free survival in breast cancer. Int J Radiat Oncol 1986; 12: 673-9.
72. Lipsett MB. Post operative radiation for women with cancer of the breast and positive axillary lymph node. Should it continue? N Engl J Med 1981; 304: 112-4.
73. Lund MB, Myhre KI, Melsom H, Johansen B. The effect on pulmonary function of tangential field technique in radiotherapy for carcinoma of the breast. Br J Radiol 1991; 64: 520-3.
74. Lythgoe JP. Manchester regional breast study. Preliminary results. Lancet 1978; 1: 744-7.
75. Lythgoe JP, Palmer. Manchester regional breast study-5 and 10 year results. Br J Surg 1982; 69: 693-6.
76. McArdle CS, Crawford D, Dykes EH, Calman KC, Hole D, Russell AR. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 1986; 73: 264-6.
77. Magee B, Ribeiro GG, Williams P, Swindell R. Use of an electron beam for post-mastectomy radiotherapy: 5-year follow-up of 500 cases. Clin Oncol 1991; 3: 310-4.
78. Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL, et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer with patients with ≥ 10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 1992; 23: 1021-6.
79. Mouridsen HT, Rose C, Overgaard M, Dombernowsky J, Panduro J, Thorpe S, et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77c and DBCG 82c. Acta Oncol 1988; 27: 699-705.
80. Muss HB, Cooper MR, Brockschmidt JK, Ferree C, Richards II F, White DR, et al. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Breast Cancer Res Treat 1991; 19: 77-84.
81. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T. Surgical adjuvant chemotherapy. Result with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1978; 41: 2088-98.
82. Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW. The role of radiotherapy in the management of operable locally advanced breast carcinoma. Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 1997; 79: 1138-49.
83. Olson JE, Neuberg D. Postmastectomy radiation. A modest benefit prevails for high risk patients [reply]. J Clin Oncol 1997; 79: 1067-8.
84. Overgaard M, Christensen JJ, Johansen H, Nyro-Ramussen A. Brincker H, van der Kooy P, et al. Post-mastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast cancer cooperative group trials. Acta Oncol 1988; 27: 707-14.
85. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-55.
86. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Kamby C, et al. Randomized trial evaluating postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen, results from the DBCG 82c trial [abstract 305]. Radiother Oncol 1998; 48 Suppl 1: 78.
87. Patanaphan V, Salazar OM, Poussin-Rocillo H. Prognosticators in recurrent breast cancer. A 15-year experience with irradiation. Cancer 1984; 54: 228-34.
88. Ragaz J, Stewart MJ, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-62.
89. th ASTRO meeting. Radiat Oncol Biol Phys 1985; 11 Suppl 1: 151.
90. Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Kkoog L, et al. Radiotherapy, chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int J Radiat Oncol Biol Phys 1989; 16: 629-39.
91. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992; 22: 887-96.
92. Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: Long-term follow up of a randomized clinical trial. Radiother Oncol 1993; 26: 104-10.
93. Ryttov N, Holm NV, Qvist N, Blichert-Toft M. Influence of adjuvant irradiation on the development of late arm lymphoedema and impaired shoulder mobility after mastectomy for carcinoma of the breast. Acta Oncol 1988; 27: 667-70.
94. Salles G, Romestaing P, Salerno N, Mahe M, Sentenac I, Gerard JP. La radiothérapie après mastectomie. Efficacité et tolérance à partir de l'étude de 557 observations. Lyon Chir 1990; 86: 376-82.
95. Sarrazin D, Le MG, Arriagada R, Contesso G, Fontaine F, Spielmann M, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14: 177-84.
96. Stefanik D, Goldberg R, Byrne P, Smith F, Ueno W, Smith L. Local-regional failure inpatients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1985; 3: 660-5.
97. Sulkes A, Brufman G, Rizel S, Weshler Z, Biran S, Fuks Z. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. Int J Radiat Oncol Biol Phys 1983; 9: 17-21.
98. Swedborg I, Wallgren A. The effect of pre- and postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force. Cancer 1981; 47: 877-81.
99. Sykes HF, Sim DA, Wong CJ, Cassady JR, Salmon SE. Local-regional recurrence in breast cancer after mastectomy and adriamycinbased adjuvant chemotherapy: Evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 641-7.
100. Tapley ND, Spanos WJ, Fletcher GH, Montague ED, Schell S, Oswald MJ. Results in patients with breast cancer treated by radical mastectomy and postoperative irradiation with no adjuvant chemotherapy. Cancer 1982; 49: 1316-9.
101. Tenvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 1993; 32: 641-6.
102. Theriault AU, Buzdar GN, Hortobagyi D, Booser L, Asmar M, McNeese E. Proceed. ASCO 1998, vol 17, 99a [abstract 381].
103. Toonkel LM, Fix I, Jacobson LH, Schneider JJ, Wallach C. Postoperative radiation therapy for carcinoma of the breast: Improved results with elective irradiation of the chest wall. Int J Radiat Oncol Biol Phys 1982; 8: 977-83.
104. Turnbull AR, Chant ADB, Buchanan RB, Turner DTL, Shepherd JM, Fraser JD. Treatment of early breast cancer. Lancet 1978; 1: 7-9.
105. Valagussa P, Bonadonna G, Veronesi US. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 1978; 41: 1170-8.
106. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992; 28: 801-5.
107. Velez-Garcia E, Carpenter JT, Moore M, Vogel CL, Marcial V, Ketcham A, et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer 1992; 28: 1833-7.
108. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extend of metastatic axillary in 1446 cases of breast cancer. Eur J Cancer 1990; 16: 127-33.